Analytical Method Validation and Formula Optimization of Topical Nanoemulsion Formulation Containing Resveratrol

https://doi.org/10.22146/ijc.63730

Christofori Maria Ratna Rini Nastiti(1*), Florentinus Dika Octa Riswanto(2)

(1) Department of Pharmacy, Faculty of Pharmacy, Sanata Dharma University, Campus III Paingan, Maguwoharjo, Depok, Sleman, Yogyakarta 55282, Indonesia
(2) Department of Pharmacy, Faculty of Pharmacy, Sanata Dharma University, Campus III Paingan, Maguwoharjo, Depok, Sleman, Yogyakarta 55282, Indonesia
(*) Corresponding Author

Abstract


Resveratrol (RSV), a natural lipophilic phytoalexin, was reported as an antioxidant and anti-inflammatory agent, which has the potential to cure diabetic wounds. However, several studies suggested the limitation of RSV, such as poor aqueous solubility, poor stability, and poor oral bioavailability. To overcome the issues, RSV was formulated as a topical nanoemulsion. It is important to ensure the quality of the dosage form by evaluating RSV load in the nanoformulation and optimizing the formula. A reversed-phase HPLC method was developed and validated prior to the load determination of RSV in the nanoemulsion formulation. The composition of triacetin-eugenol, Kolliphor® RH 40, and Transcutol® was further optimized by employing a Box-Behnken Design (BBD) to achieve the optimum composition with expected viscosity and RSV load. The HPLC method for determining RSV load was successfully validated for parameters of selectivity with the resolution of 8.487, linearity and range (r = 0.9979), precision (0.12% of RSD), accuracy (109–110% of recovery), the limit of detection (0.574 µg/mL), and limit of quantitation (1.740 µg/mL). The result of formula optimization was promising, showing the optimum composition of triacetin-eugenol, Kolliphor® RH 40, and Transcutol® at 4.44 g, 30.97 g, and 11.39 g, respectively.


Keywords


Box-Behnken design; formulation; nanoemulsion; resveratrol; validation

Full Text:

Full Text PDF


References

[1] Huang, X., Sun, J., Chen, G., Niu, C., Wang, Y., Zhao, C., Sun, J., Huang, H., Huang, S., Liang, Y., Shen, Y., Cong, W., Jin, L., and Zhu, Z., 2019, Resveratrol promotes diabetic wound healing via SIRT1-FoxO1-c-Myc signaling pathway-mediated angiogenesis, Front. Pharmacol., 10, 421.

[2] McKittrick, L.S., McKittrick, J.B., and Risley, T.S., 1949, Transmetatarsal amputation for infection or gangrene in patients with diabetes mellitus, Ann. Surg., 130 (4), 826–840.

[3] Ammendola, M., Sacco, R., Butrico, L., Sammarco, G., de Franciscis, S., and Serra, R., 2017, The care of transmetatarsal amputation in diabetic foot gangrene, Int. Wound J., 14 (1), 9–15.

[4] Zhou, X., Ruan, Q., Ye, Z., Chu, Z., Xi, M., Li, M., Hu, W., Guo, X., Yao, P., and Xie, W., 2021, Resveratrol accelerates wound healing by attenuating oxidative stress-induced impairment of cell proliferation and migration, Burns, 47 (1), 133–139.

[5] Sanders, T.H., McMichael, R.W., and Hendrix, K.W., 2000, Occurrence of resveratrol in edible peanuts, J. Agric. Food Chem., 48 (4), 1243–1246.

[6] Frémont, L., 2000, Biological effects of resveratrol, Life Sci., 66 (8), 663–673.

[7] Amri, A., Chaumeil, J.C., Sfar, S., and Charrueau, C., 2012, Administration of resveratrol: What formulation solutions to bioavailability limitations?, J. Controlled Release, 158 (2), 182–193.

[8] Nastiti, C.M.R.R., Ponto, T., Mohammed, Y., Roberts, M.S., and Benson, H.A.E., 2020, Novel nanocarriers for targeted topical skin delivery of the antioxidant resveratrol, Pharmaceutics, 12 (2), 108.

[9] Bastianetto, S., Ménard, C., and Quirion, R., 2015, Neuroprotective action of resveratrol, Biochim. Biophys. Acta, Mol. Basis Dis., 1852 (6), 1195–1201.

[10] Diaz-Gerevini, G.T., Repossi, G., Dain, A., Tarres, M.C., Das, U.N., and Eynard, A.R., 2016, Beneficial action of resveratrol: How and why?, Nutrition, 32 (2), 174–178.

[11] Hermann, D.M., Zechariah, A., Kaltwasser, B., Bosche, B., Caglayan, A.B., Kilic, E., and Doeppner, T.R., 2015, Sustained neurological recovery induced by resveratrol is associated with angioneurogenesis rather than neuroprotection after focal cerebral ischemia, Neurobiol. Dis., 83, 16–25.

[12] Zordoky, B.N.M., Robertson, I.M., and Dyck, J.R.B., 2014, Preclinical and clinical evidence for the role of resveratrol in the treatment of cardiovascular diseases, Biochim. Biophys. Acta, Mol. Basis Dis., 1852 (6), 1155–1177.

[13] Dyck, G.J.B., Raj, P., Zieroth, S., Dyck, J.R.B., and Ezekowitz, J.A., 2019, The effects of resveratrol in patients with cardiovascular disease and heart failure: A narrative review, Int. J. Mol. Sci., 20 (4), 904.

[14] Öztürk, E., Arslan, A.K.K., Yerer, M.B., and Bishayee, A., 2017, Resveratrol and diabetes: A critical review of clinical studies, Biomed. Pharmacother., 95, 230–234.

[15] Szkudelski, T., and Szkudelska, K., 2015, Resveratrol and diabetes: From animal to human studies, Biochim. Biophys. Acta, Mol. Basis Dis., 1852 (6), 1145–1154.

[16] Farris, P., Krutmann, J., Li, Y.H., McDaniel, D., and Krol, Y., 2013, Resveratrol: A unique antioxidant offering a multi-mechanistic approach for treating aging skin, J. Drugs Dermatology, 12 (12), 1389–1394.

[17] Ratz-Łyko, A., and Arct, J., 2019, Resveratrol as an active ingredient for cosmetic and dermatological applications: A review, J. Cosmet. Laser Ther., 21 (2), 84–90.

[18] Francioso, A., Mastromarino, P., Masci, A., D’Erme, M., and Mosca, L., 2014, Chemistry, stability and bioavailability of resveratrol, Med. Chem., 10 (3), 237–245.

[19] Walle, T., Hsieh, F., DeLegge, M.H., Oatis, J.E., and Walle, U.K., 2004, High absorption but very low bioavailability of oral resveratrol in humans, Drug Metab. Dispos., 32 (12), 1377–1382.

[20] Sharma, B., Iqbal, B., Kumar, S., Ali, J., and Baboota, S., 2019, Resveratrol-loaded nanoemulsion gel system to ameliorate UV-induced oxidative skin damage: From in vitro to in vivo investigation of antioxidant activity enhancement, Arch. Dermatol. Res., 311 (10), 773–793.

[21] Khurana, B., Arora, D., and Narang, R.K., 2020, FbD supported development and in vitro evaluation of carbomer based resveratrol loaded topical antipsoriatic nanoemulgel for its targeted skin delivery, Pharm. Nanotechnol., 8 (2), 91–107.

[22] Sun, R., Zhao, G., Ni, S., and Xia, Q., 2014, Lipid based nanocarriers with different lipid compositions for topical delivery of resveratrol: Comparative analysis of characteristics and performance, J. Drug Delivery Sci. Technol., 24 (6), 591–600.

[23] Pal, R., 2016, Modeling the viscosity of concentrated nanoemulsions and nanosuspensions, Fluids, 1 (2), 11.

[24] Aqil, M., Kamran, M., Ahad, A., and Imam, S.S., 2016, Development of clove oil based nanoemulsion of olmesartan for transdermal delivery: Box–Behnken design optimization and pharmacokinetic evaluation, J. Mol. Liq., 214, 238–248.

[25] Kumbhar, S.A., Kokare, C.R., Shrivastava, B., Gorain, B., and Choudhury, H., 2020, Preparation, characterization, and optimization of asenapine maleate mucoadhesive nanoemulsion using Box-Behnken design: In vitro and in vivo studies for brain targeting, Int. J. Pharm., 586, 119499.

[26] Sharma, A., Singh, A.P., and Harikumar, S.L., 2020, Development and optimization of nanoemulsion based gel for enhanced transdermal delivery of nitrendipine using Box-Behnken statistical design, Drug Dev. Ind. Pharm., 46 (2), 329–342.

[27] Sood, S., Jain, K., and Gowthamarajan, K., 2014, Optimization of curcumin nanoemulsion for intranasal delivery using design of experiment and its toxicity assessment, Colloids Surf., B, 113, 330–337.

[28] Riswanto, F.D.O., Rohman, A., Pramono, S., and Martono, S., 2019, Application of response surface methodology as mathematical and statistical tools in natural product research, J. Appl. Pharm. Sci., 9 (10), 125–133.

[29] Riswanto, F.D.O., Rohman, A., Pramono, S., and Martono, S., 2020, Employing an R software package rsm for optimizing of genistein, daidzein, and glycitein separation and its application for soy milk analysis by HPLC method, Indones. J. Chem., 20 (5), 1184–1198.

[30] Ferreira, S.L.C., Bruns, R.E., Ferreira, H.S., Matos, G.D., David, J.M., Brandão, G.C., da Silva, E.G.P., Portugal, L.A., dos Reis, P.S., Souza, A.S., and dos Santos, W.N.L., 2007, Box-Behnken design: An alternative for the optimization of analytical methods, Anal. Chim. Acta, 597 (2), 179–186.

[31] Dwiastuti, R., Marchaban, M., Istyastono, E.P., and Riswanto, F.D.O., 2018, Analytical method validation and determination of free drug content of 4-n-butylresorcinol in complex lipid nanoparticles using RP-HPLC method, Indones. J. Chem., 18 (3), 496–502.

[32] Lenth, R.V., 2009, Response-surface methods in R, using RSM, J. Stat. Softw., 32 (7), 1–17.

[33] AOAC International, 2013, AOAC Official Methods of Analysis - Appendix K: Guidelines for Dietary Supplements and Botanicals, AOAC International, Rockville, MD.

[34] Miller, J.M., and Miller, J.C., 2010, Statistics and Chemometrics for Analytical Chemistry, 6th Ed., Pearson Education Limited, Harlow.

[35] Shiyan, S., Hertiani, T., Martien, R., and Nugroho, A.K., 2019, Optimization and validation of RP-HPLC/UV detection for several compounds simultaneously in semi-purified extract of white tea, Rasayan J. Chem., 12 (3), 1098–1109.

[36] Snyder, L.R., Kirkland, J.J., and Dolan, J.W., 2010, Introduction to Modern Liquid Chromatography, 3rd Ed., John Wiley & Sons, Inc., New Jersey.

[37] Riswanto, F.D.O., Lukitaningsih, R.R.E., and Martono, S., 2015, Analytical method validation and determination of pyridoxine, nicotinamide, and caffeine in energy drinks using thin layer chromatography-densitometry, Indones. J. Chem., 15 (1), 9–15.

[38] Sobhani, H., Tarighi, P., Ostad, S.N., Shafaati, A., Nafissi-Varcheh, N., and Aboofazeli, R., 2015, Formulation development and toxicity assessment of triacetin mediated nanoemulsions as novel delivery systems for rapamycin, Iran. J. Pharm. Res., 14, 3–21.

[39] Quan, D., Deshpanday, N.A., Venkateshwaran, S., and Ebert, C.D., 1998, Triacetin as a penetration enhancer for transdermal delivery of a basic drug, US Patent No. 5834010A, Washington, DC.

[40] Zhao, K., and Singh, J., 1998, Mechanisms of percutaneous absorption of tamoxifen by terpenes: Eugenol, D-limonene and menthone, J. Controlled Release, 55 (2), 253–260.

[41] Guan, Y., Wu, J., and Zhong, Q., 2016, Eugenol improves physical and chemical stabilities of nanoemulsions loaded with β-carotene, Food Chem., 194, 787–796.

[42] Pharmaceutical, 2019, Kolliphor® RH 40, https://pharmaceutical.basf.com/global/en/drug-formulation/products/kolliphor-rh40.html, accessed: January 27, 2021.

[43] Purba, N.B.R., Rohman, A., and Martono, S., 2019, The optimization of HPLC for quantitative analysis of Acid Orange 7 and Sudan II in cosmetic products using Box Behnken design, Int. J. Appl. Pharm., 11 (2), 130–137.

[44] Amdoun, R., Khelifi, L., Khelifi-Slaoui, M., Amroune, S., Asch, M., Assaf-Ducrocq, C., and Gontier, E., 2018, The desirability optimization methodology; A tool to predict two antagonist responses in biotechnological systems: Case of biomass growth and hyoscyamine content in elicited Datura starmonium hairy roots, Iran. J. Biotechnol., 16 (1), e1339.

[45] Poonia, N., Lather, V., Kaur, B., Kirthanashri, S.V., and Pandita, D., 2020, Optimization and Development of Methotrexate- And Resveratrol-Loaded Nanoemulsion Formulation Using Box-Behnken Design for Rheumatoid Arthritis, Assay Drug Dev. Technol., 18 (8), 356–368.



DOI: https://doi.org/10.22146/ijc.63730

Article Metrics

Abstract views : 1823 | views : 1426


Copyright (c) 2021 Indonesian Journal of Chemistry

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

 


Indonesian Journal of Chemistry (ISSN 1411-9420 / 2460-1578) - Chemistry Department, Universitas Gadjah Mada, Indonesia.

Web
Analytics View The Statistics of Indones. J. Chem.